Berlin, Germany

Matthias Renz

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthias Renz: Innovator in Pharmaceutical Compounds

Introduction

Matthias Renz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Matthias Renz holds a patent for "Substituted tricyclic compounds and methods of use thereof." This invention relates to novel compounds and processes for their preparation. It also includes methods of treating diseases, particularly cancer, by administering these compounds. Furthermore, it outlines methods for creating pharmaceutical compositions aimed at the treatment or prevention of disorders, especially cancer.

Career Highlights

Throughout his career, Matthias Renz has worked with prominent companies in the pharmaceutical and automotive sectors. He has been associated with Bayer Intellectual Property GmbH, where he contributed to the development of innovative solutions. Additionally, he has worked with Harman Becker Automotive Systems GmbH, further showcasing his versatility and expertise in different industries.

Collaborations

Matthias Renz has collaborated with several professionals in his field, including Hartmut Schirok and Ying Li-Sommer. These collaborations have likely enriched his work and contributed to the success of his inventions.

Conclusion

Matthias Renz is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact cancer treatment significantly. His innovative spirit and collaborations with industry leaders highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…